Lana Gorenec - Infectious Diseases

Author Information

Lana Gorenec is affiliated with the University Hospital for Infectious Diseases, specifically within the Department of Molecular Diagnostics and Flow Cytometry, located in Zagreb, Croatia. Her research focuses primarily on infectious diseases, with a special interest in virology and immunology, as evidenced by her publications.

Research Contributions

Lana Gorenec has made significant contributions to the field of infectious diseases, particularly concerning viral infections such as West Nile Virus and hepatitis. Her research has explored various aspects of these diseases, including clinical characteristics, virological and immunological findings, and the genetic factors influencing disease progression and treatment resistance. She has investigated neuroinvasive diseases, cytokine responses, and resistance mutations, providing valuable insights into the clinical and molecular dynamics of these infections.

Aliases

Lana Gorenec is also known by the aliases L Gorenec and L. Gorenec in various academic and research publications.

Publication and Citation Metrics

Metric	Value
Total Papers	29
Total Citations	139
H-index	7

Publications:

Severe West Nile Virus Neuroinvasive Disease: Clinical Characteristics, Short- and Long-Term Outcomes

DOI: 10.3390/pathogens11010052

Year: 2022

Antiviral Cytokine Response in Neuroinvasive and Non-Neuroinvasive West Nile Virus Infection

DOI: 10.3390/v13020342

Year: 2021

Clinical, Virological, and Immunological Findings in Patients with Toscana Neuroinvasive Disease in Croatia: Report of Three Cases

DOI: 10.3390/tropicalmed5030144

Year: 2020

Hepatitis B virus genotyping, detection of reverse transcriptase resistance and immune escape mutations in persons with chronic hepatitis B from Croatia

DOI: 10.33602/mebm.3.1.4

Year: 2020

FRI-244-Platelet-derived growth factor alpha might mediate hepatic fibrosis by enhancing insulin resistance in patients with hepatitis C

DOI: 10.1016/S0618-8278(19)30989-2

Year: 2019

Kvantifikacija ribonukleinske kiseline (RNA) HIV-a tipa 2

DOI:

Year: 2018

Primarna rezistencija HIV-a na antiretrovirusne lijekove

DOI:

Year: 2018

Resistance to NS3 protease inhibitors in persons with chronic hepatitis C virus subtype 1a from Croatia

DOI: 10.1186/s12879-016-1480-8

Year: 2018

PHARMACOGENETICS TESTING FOR HLA-B*57:01 ALLELE BY SCREENING ASSAYS AND HIGH RESOLUTION HLA-TYPING: RESULTS FROM A COMPLETE NATIONAL HIV COHORT, CROATIA

DOI:

Year: 2018

The association of semaphorins 3C, 5A and 6D with liver fibrosis stage in chronic hepatitis C

DOI: 10.1371/journal.pone.0209481

Year: 2018

What is the Future of Infectious Diseases Training?

How do Antimicrobial Resistance (AMR) Affect Mortality?

When is Dexamethasone prescribed in infectious diseases?

Who Should Get Regular Health Check-Ups?

What is Herpes Simplex Virus (HSV)?

How Do Proteomic Studies Contribute?

When to Seek Medical Attention?

What are the global statistics?

What is Salmonella?

How Does COVID-19 Spread?

Partnered Content Networks

Relevant Topics